Medicare Enrolled

Dr. Mike Cusnir, M.D.

Optician · Miami Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
4306 ALTON RD, Miami Beach, FL 33140
3055353337
In practice since 2005 (20 years)
NPI: 1962490631 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cusnir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cusnir? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cusnir

Dr. Mike Cusnir is an optician in Miami Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Cusnir performed 853 Medicare services across 335 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cusnir received a total of $248,277 from 109 pharmaceutical and/or device companies across 2525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cusnir is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 853 Medicare services$ $248,277 industry payments

Medicare Practice Summary

Medicare Utilization ↗
853
Medicare services
Bottom 39% in FL for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
335
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)609$51$165
Office visit, established patient (30-39 min)135$81$252
Hospital follow-up visit, moderate complexity83$65$228
New patient office visit (45-59 min)14$109$433
New patient office visit (30-44 min)12$62$257
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$248,277
Total received (2018-2024)
Avg $35,468/year across 7 years
Top 1% in FL for optician
109
Companies
2,525
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$167,171 (67.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,700 (17.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,406 (15.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,146
2023
$30,633
2022
$35,125
2021
$28,912
2020
$14,378
2019
$34,968
2018
$84,115

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sirtex Medical Inc
$137,303
Genentech USA, Inc.
$18,389
Ipsen Biopharmaceuticals, Inc
$12,169
Lilly USA, LLC
$11,771
Seagen Inc.
$7,684
AstraZeneca Pharmaceuticals LP
$7,496
Eisai Inc.
$6,073
Celgene Corporation
$4,364
PFIZER CHILE S.A.
$3,905
Janssen Biotech, Inc.
$2,671
PFIZER INC.
$2,165
SANOFI-AVENTIS U.S. LLC
$2,075
Novartis Pharmaceuticals Corporation
$2,035
BeiGene USA, Inc.
$2,008
EISAI INC.
$1,837
Astellas Pharma US Inc
$1,569
TAIHO ONCOLOGY, INC.
$1,545
Incyte Corporation
$1,493
E.R. Squibb & Sons, L.L.C.
$1,286
Merck Sharp & Dohme Corporation
$1,168
EMD Serono, Inc.
$1,163
ARRAY BIOPHARMA INC
$1,083
GENZYME CORPORATION
$1,030
Amgen Inc.
$939
Bayer HealthCare Pharmaceuticals Inc.
$882
Daiichi Sankyo Inc.
$749
Exelixis Inc.
$628
Merck Sharp & Dohme LLC
$584
Epizyme, Inc.,
$574
Bayer Healthcare Pharmaceuticals Inc.
$506
Pharmacyclics LLC, An AbbVie Company
$480
Gilead Sciences, Inc.
$466
BeiGene, Ltd.
$450
Regeneron Healthcare Solutions, Inc.
$426
Mirati Therapeutics, Inc.
$385
Foundation Medicine, Inc.
$384
GlaxoSmithKline, LLC.
$381
Janssen Pharmaceuticals, Inc
$360
Clovis Oncology, Inc.
$356
Takeda Pharmaceuticals U.S.A., Inc.
$323
Boehringer Ingelheim Pharmaceuticals, Inc.
$305
Sumitomo Pharma America, Inc.
$283
Pharmacyclics LLC, an AbbVie Company
$279
Deciphera Pharmaceuticals Inc.
$278
Tempus AI, Inc
$269
ABBVIE INC.
$257
Adaptive Biotechnologies Corporation
$244
AbbVie Inc.
$234
Karyopharm Therapeutics Inc.
$219
Taiho Oncology, Inc.
$195
ADC Therapeutics America, Inc.
$190
MEDIVATION FIELD SOLUTIONS LLC
$187
Kyowa Kirin, Inc.
$185
Kite Pharma, Inc.
$184
MorphoSys, US Inc.
$182
Janssen Scientific Affairs, LLC
$180
Myriad Genetic Laboratories, Inc.
$179
G1 Therapeutics, Inc.
$166
EUSA Pharma (US) LLC
$158
JAZZ PHARMACEUTICALS INC.
$149
SpringWorks Therapeutics, Inc.
$141
Rigel Pharmaceuticals, Inc.
$139
Myovant Sciences Inc.
$127
Dendreon Pharmaceuticals LLC
$127
Seattle Genetics, Inc.
$117
SERVIER PHARMACEUTICALS LLC
$116
Genmab U.S., Inc.
$112
Jazz Pharmaceuticals Inc.
$107
Dova Pharmaceuticals
$106
SOBI, INC
$103
Array BioPharma Inc.
$99
SEAGEN INC.
$99
TESARO, Inc.
$88
Alexion Pharmaceuticals, Inc.
$84
Aurobindo Pharma USA, Inc.
$82
AbbVie, Inc.
$78
Agios Pharmaceuticals, Inc.
$72
Acceleron Pharma, Inc.
$72
Spectrum Pharmaceuticals Inc.
$66
Stemline Therapeutics Inc.
$59
Teva Pharmaceuticals USA, Inc.
$58
Pharmacosmos Therapeutics Inc.
$55
Apellis Pharmaceuticals, Inc.
$49
Epizyme, Inc.
$45
AVEO Pharmaceuticals, Inc.
$43
Alnylam Pharmaceuticals Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$41
Verastem, Inc.
$35
CTI BioPharma Corp.
$34
Helsinn Therapeutics (U.S.), Inc.
$32
Boston Scientific Corporation
$30
Sun Pharmaceutical Industries Inc.
$30
Otsuka America Pharmaceutical, Inc.
$27
Shire North American Group Inc
$27
Aveo Pharmaceuticals, Inc.
$27
ImmunoGen, Inc.
$25
AMAG Pharmaceuticals, Inc.
$23
Puma Biotechnology, Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
TerSera Therapeutics LLC
$20
Blue Earth Diagnostics Limited
$20
Partner Therapeutics, Inc.
$18
Tolmar, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$17
Medtronic USA, Inc.
$15
Blueprint Medicines Corporation
$15
Advanced Accelerator Applications
$13
Midatech Pharma US Inc
$9
Veracyte, Inc.
$0
Top 3 companies account for 67.6% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKEEGA · AKYNZEO · ALIMTA · AVVIGO Guidance System · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BALVERSA · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONACT · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Gelclair · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LEUKINE · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lupron · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNCHROMED · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TRELEGY ELLIPTA · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optician in FL.

Equivalent to $29,106 per 100 Medicare services performed
Looking for a optician in Miami Beach?
Compare opticians in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
711
Per 100K population
26.5
County median income
$68,694
Nearest hospital
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cusnir is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cusnir experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Cusnir performed 609 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cusnir receive payments from pharmaceutical companies?
Yes. Dr. Cusnir received a total of $248,277 from 109 companies across 2,525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cusnir's costs compare to other opticians in Miami Beach?
Dr. Cusnir's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cusnir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →